Navigation Links
Ex-Allergan Vice President Joins Kalologie Skincare Board of Directors
Date:3/19/2008

SANTA MONICA, Calif., March 19 /PRNewswire/ -- Kalologie Skincare today announced that Niv Edward Caviar, Executive Vice President of La Jolla Pharmaceutical Company, was elected to Kalologie Skincare's board of directors. Mr. Caviar previously served as Vice President of Allergan Inc.

"Niv is a strong marketer with solid operational skills," said William Brennan, Kalologie's CEO. "We look forward to benefiting from Niv's unique insight in the growing aesthetic skin care industry."

"Over the past five years, Kalologie has positioned itself to become a leading provider of aesthetic skin care products and services," said Niv Edward Caviar. "I look forward to working with the Company to help facilitate future growth, especially through the company's physician-only franchise program."

At Allergan, Mr. Caviar was Vice-President of Business Development and then Vice-President and Head of Marketing for Medical Dermatology. In his latter role, Mr. Caviar led all operational and strategic marketing activities for Allergan's U.S medical dermatology franchise. Brands under his responsibility included Tazorac(R), Avage(R), and Botox(R) for Medical Dermatology uses. Mr. Caviar is presently Executive Vice-President and Chief Business and Financial Officer of La Jolla Pharmaceutical Co., a San Diego-based biotech company focused on developing innovative pharmaceutical products. La Jolla Pharmaceutical's leading product in development is Riquent(R) (abetimus sodium), which is currently being studied to help treat and maintain remission in patients with lupus renal disease.

Mr. Caviar received an M.B.A. from Harvard University and a B.S. in Mechanical Engineering from the U.S. Air Force Academy. Prior to his work at Allergan, Mr. Caviar served as a captain in the U.S. Air Force where he worked as a Solid Rocket Motor Engineer and was a Project Manager for the U.S. Space Command on both the Titan IV Rocket and the Space Shuttle Solid Rocket Motor Programs.

Founded in 2003, Kalologie is a chain of comprehensive, one-stop skin care clinics offering effective medical and aesthetic skin care treatments such as Botox(R), Juvederm, Restylane, IPL Photo Facials, Laser Hair Removal, Facials and Chemical Peels. In addition the Company offers a proprietary line of Kalologie-branded skin care products.

Kalologie Franchising, LLC, with headquarters in Santa Monica, California, is a solution-oriented skin care company offering a comprehensive approach to address the unique challenges of each individual's skin. http://www.kalologie.com

For press inquiries, please contact Sarah Lopez; sarah_lopez@kalologie.com; (310) 961-2077.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Kalologie Franchising, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Three CEOs and University President Named Winners of Greater Baltimore Committees 2008 Baltimore Region Bioscience Awards
2. Dr. Linda McAllister Joins Arbor Vita Corporation as Vice President of Diagnostics
3. iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs
4. Cato Research Names John Cline as President
5. Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales
6. febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales
7. Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
8. Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer
9. MiMedx Announces Brian J. Splan as President
10. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
11. Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... , January 20, 2017 ... is one of leading causes of death worldwide. There ... the number of cancer related deaths increased gradually over ... in incidence rate of various cancers continues to drive ... research report by Global Market Insights, Inc. cancer biological ...
(Date:1/19/2017)... Research Future has a half cooked research report on Global Liquid ... and expected to reach USD 450 Million by the end of ... ... assessed as a swiftly growing market and expected that the market ... There has been a tremendous growth in the prevalence of cancer ...
(Date:1/19/2017)... and Markets ... addition of the "Implantable Biomaterials Market Analysis & ... to their offering. Report Highlights: ... current and future market trends to identify the investment opportunities ... numbers Key market trends across the business segments, Regions ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, 2017 /PRNewswire/ ... a privately-held immunotherapeutics company targeting infectious diseases, announced ... the merger of PharmAthene and Altimmune in an ... Fund, HealthCap, Truffle Capital and Redmont Capital. The ... immunotherapeutics company with four clinical stage and one ...
Breaking Biology Technology:
(Date:1/3/2017)... VEGAS , Jan. 3, 2017 Onitor, ... the introduction of Onitor Track, an innovative biometric data-driven ... men, showcasing this month at the 2017 Consumer Electronics ... In the U.S., the World Health ... more than two-thirds of adults who are overweight or ...
(Date:12/20/2016)... 20, 2016   Valencell , the leading ... STMicroelectronics (NYSE: STM), a global semiconductor leader ... announced today the launch of a new, highly ... that includes ST,s compact SensorTile turnkey ... biometric sensor system. Together, SensorTile and Benchmark deliver ...
(Date:12/16/2016)... The global wearable medical device market, in terms of ... USD 5.31 billion in 2016, at a CAGR of 18.0% during ... ... in medical devices, launch of a growing number of smartphone-based healthcare ... healthcare providers, and increasing focus on physical fitness. ...
Breaking Biology News(10 mins):